Structural determinants of long-term functional outcomes in young children with cystic fibrosis

Lidija Turkovic1, Daan Caudri2,3,4, Tim Rosenow2,5

  • 1Telethon Kids Institute, Perth, Australia lidijat@gmail.com.

Insights

Early chest CT scans in children with cystic fibrosis (CF) can predict future lung function decline. Identifying structural lung disease early with CT scans is crucial for improving CF patient outcomes.

Area of Science:

  • Pediatric Pulmonology
  • Radiology
  • Cystic Fibrosis Research

Background:

  • Accelerated lung function decline in cystic fibrosis (CF) begins in adolescence.
  • Respiratory complications are the primary cause of mortality in later life.
  • The relationship between early childhood structural lung disease and lung function decline is not well understood.

Purpose of the Study:

  • To investigate the association between early childhood structural lung disease detected by chest CT and long-term lung function in CF patients.
  • To determine if chest CT findings in early childhood can predict adverse long-term outcomes in CF.
  • To assess the utility of chest CT in monitoring disease progression and therapeutic response in CF.

Main Methods:

  • Utilized annual chest computed tomography (CT) scans from the AREST CF cohort (2005-2016) for children aged 3 months to 6 years.
  • Collected annual spirometry data from age 5 to 15 years for 167 children (89.77% of the cohort).
  • Analyzed CT scores and spirometry measurements (forced expiratory volume in 1 second - FEV1) to identify correlations.

Main Results:

  • Children with CT scores above the median at age 5-6 years were significantly more likely to have abnormal FEV1 in the subsequent 10 years (adjusted hazard ratio 2.67, p=0.037).
  • Structural abnormalities on CT, excluding bronchial wall thickening, correlated with lower FEV1 Z-scores.
  • Mucus plugging and air trapping were the most predictive CT sub-scores for reduced FEV1 (p<0.001 for both).

Conclusions:

  • Chest CT scans in early childhood can identify children with cystic fibrosis at risk for adverse long-term outcomes.
  • Preventing structural lung damage through early intervention, assessed by CT, is a key goal for improving CF patient prognosis.
  • Chest CT serves as an early indicator of potential long-term treatment success in the evolving therapeutic landscape for CF.
Abstract

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
387
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
647
Information Processing Approach01:30

Information Processing Approach

The information-processing theory of cognitive development centers on fundamental mental processes, including attention, memory, and problem-solving skills. Researchers in this field examine how cognitive abilities, such as working memory, evolve and influence children's overall development. Studies indicate that children with stronger working memory tend to excel in reading comprehension, math, and problem-solving compared to peers with less efficient memory skills. Low working memory is...
416
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
143